Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Parallel-Group 6-Week Treatment Clinical Study to Assess BE of Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Comparison With Reference Product, Symbicort® in Adult Asthma Patients

NCT05322707 is registered in ClinicalTrials.gov with Cipla Ltd. as lead sponsor.

NCT NCT05322707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05322707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Parallel-Group 6-Week Treatment Clinical Study to Assess BE of Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Comparison With Reference Product, Symbicort® in Adult Asthma Patients
Lead sponsor
Cipla Ltd.
Phase
Phase 3
Overall status
Completed
Start date
April 15, 2022
Completion date
August 29, 2023
Enrollment
1,485 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma